PMA
P100049: LINX REFLUX MANAGEMENT SYSTEM
FDA PMA · IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX · Torax Medical
Key facts
| PMA number | P100049 |
|---|---|
| Trade name | LINX REFLUX MANAGEMENT SYSTEM |
| Generic name | IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX |
| Applicant | Torax Medical |
| Owner/operator | Torax Medical Inc. |
| Product code | LEI |
| Approval date | Mar 22, 2012 |
| Docket number | 12M-0893 |
| Notice date | Aug 14, 2012 |
| Establishment registration | 3008766073 |
| FEI number | 3008766073 |
At a glance
- 10–99 Supplements
- Jan 16, 2026 Latest supplement decision
- No Withdrawn
- Yes Summary of safety and effectiveness on file
- 10–99 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: